marketing

The agency sends warning letters to makers of products that claim to prevent or treat Alzheimer’s and other diseases, and announces changes to its enforcement practices.

Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.

Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.